Sofinnova Investments, Inc. Amgen Inc Transaction History

Sofinnova Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $8.6 Million - $10.1 Million	-40,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $381,202 - $422,916	1,632 Added 4.2%	40,500 $9.87 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $27.9 Million - $32.5 Million	-125,795 Reduced 76.4%	38,868 $9.67 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $11.5 Million - $13.7 Million	53,044 Added 47.52%	164,663 $37.9 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $26.2 Million - $29.1 Million	111,619 New	111,619 $28.4 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $17.5 Million - $22.4 Million	-92,300 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $16.1 Million - $19.3 Million	92,300 New	92,300 $17.9 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.